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found that the Polo box domain of Cdc5
facilitates adaptation by localizing this
kinase to centrosomes, where it
promotes cell-cycle re-entry together
with the RSC chromatin-remodeling
complex.
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Cell-cycle checkpoints are essential feedbackmech-
anisms that promote genome integrity. However,
in the face of unrepairable DNA lesions, bypass
mechanisms can suppress checkpoint activity and
allow cells to resume proliferation. The molecular
mechanisms underlying this biological response
are currently not understood. Taking advantage of
unique separation-of-function mutants, we show
that the Polo-like kinase (PLK) Cdc5 uses a phospho-
priming-based interaction mechanism to suppress
G2/M checkpoint arrest by targeting Polo kinase ac-
tivity to centrosomes. We also show that key sub-
units of the evolutionarily conserved RSC complex
are critical downstream effectors of Cdc5 activity
in checkpoint suppression. Importantly, the lethality
and checkpoint defects associated with loss of
Cdc5 Polo box activity can be fully rescued by
artificially anchoring Cdc5 kinase domain to yeast
centrosomes. Collectively, our results highlight a
previously unappreciated role for centrosomes as
key signaling centers for the suppression of cell-
cycle arrest induced by persistent or unrepairable
DNA damage.INTRODUCTION
The formation of DNA double-strand breaks (DSBs) in eukaryotic
genomes activates an evolutionarily conserved checkpoint
response necessary for cell survival andmaintenance of genome
stability. Upon activation of the DNA damage checkpoint, cells
experience a reversible cell-cycle arrest that provides time to
repair the genome without risking further damage associated
with cell-cycle progression (reviewed in Panier and Durocher,
2013; Reinhardt and Yaffe, 2013; Shaltiel et al., 2015). Cells
that eventually complete DNA repair silence the DNA damage
checkpoint and return to a proliferative state through a process
termed recovery (Cle´menson and Marsolier-Kergoat, 2009;
Shaltiel et al., 2015). Completion of DNA repair is, however, not1422 Cell Reports 14, 1422–1434, February 16, 2016 ª2016 The Authan absolute prerequisite for cells to continue cycling. In the pro-
cess of adaptation to DNA damage, cells resume the cell cycle
by turning off the DNA damage checkpoint even though the
genome is still damaged (reviewed in Cle´menson and Marso-
lier-Kergoat, 2009; Serrano and D’Amours, 2014). This adapta-
tion response is likely to be beneficial to cells experiencing
low levels of unrepairable DNA damage because segregation
of this damage to one of the daughter cells during mitosis would
enable survival of the other cell (whereas no cell would survive a
permanent cell-cycle arrest; Clerici et al., 2014; Galgoczy and
Toczyski, 2001). Ultimately, the precise coordination between
checkpoint activation, inactivation, and cell-cycle progression
plays a critical role in determining the specific outcome of the
cellular response to DNA damage.
In eukaryotic cells, the coordination between cell-cycle events
depends on a small number of key protein kinases. Among
those, members of the Polo-like kinase (PLK) family play critical
roles in the regulation of cell division and in the maintenance
of genome integrity (Archambault et al., 2015; Reinhardt and
Yaffe, 2013; von Schubert and Nigg, 2013). PLKs have a general
architecture that is conserved among all family members. Their
catalytic serine/threonine kinase domain is found at the N termi-
nus of the protein, whereas their C-terminal end contains a
Polo-box domain (PBD). The latter is a signature domain for
PLKs and is composed of one or two similar motifs named
Polo-box (Golsteyn et al., 1996). The PBD has been character-
ized as a phospho-serine/threonine-binding domain responsible
for targeting PLKs to specific mitotic substrates and/or to spe-
cific subcellular localization during the cell cycle (reviewed in
Archambault et al., 2015; Reinhardt and Yaffe, 2013). Our group,
together with others, has previously shown that yeast mutants
that are specifically defective in Cdc5 phosphopeptide-binding
activity are viable and have no strong defect in cell-cycle pro-
gression (Chen andWeinreich, 2010; Ratsima et al., 2011). How-
ever, these PBDmutants display a specific failure to enrich Cdc5
protein at spindle pole bodies (SPBs) and to maintain cellular
ploidy (Ratsima et al., 2011). Similar mutants in human Plk1
show a specific defect in cytokinesis (Burkard et al., 2009). Given
the wide range of mitotic functions regulated by PLKs/Cdc5, it is
likely that the PBD-specific activity of Cdc5 will contribute to
additional processes (Hanisch et al., 2006; Seong et al., 2002).
Consistent with this possibility, complete removal of Cdc5’s
PBD results in lethality in yeast (Park et al., 2004; Ratsimaors
et al., 2011), a phenotype much more severe than that of phos-
phopeptide-binding-defective mutants. How the PBD might
contribute to cellular viability, however, is currently unknown.
In this study, we investigate the contribution of Cdc5’s PBD
domain to the regulation of the cellular response to DNA dam-
age. Previous work using a kinase-domain-specific mutant of
CDC5, cdc5-ad, showed that Cdc5 activity is required to silence
checkpoint activation in the presence of persistent DNA damage
and to allow cells to return to a cycling state (Toczyski et al.,
1997). Several distinct proteins have been proposed as targets
of Cdc5 in the adaptation response (Donnianni et al., 2010;
Hu et al., 2001; Liang and Wang, 2007; Schleker et al., 2010;
Valerio-Santiago et al., 2013; Vidanes et al., 2010; Zhang et al.,
2009), but it remains unclear how the adaptation process is
executed in vivo. In particular, whether Cdc5 acts exclusively
or even predominantly through its mitotic substrates Bfa1 and
Cdh1 to promote adaptation is a key question (reviewed in
Serrano and D’Amours, 2014). Here, we take advantage of a
unique separation-of-function mutant in yeast, cdc5-16, to
reveal fundamental mechanistic insights into the role of Cdc5
in the DNA damage response. Our results show that the phos-
phopeptide-binding activity of Cdc5 PBD is essential to mediate
adaptation to persistent DNA damage and acts by targeting
Cdc5 kinase activity to the yeast centrosomes/SPB. Importantly,
we identify the RSC chromatin-remodeling complex as a regu-
lator and/or downstream effector of Cdc5 in the adaptation
response to DNA damage. Taken together, our results provide
critical insights into the mechanisms used by eukaryotic cells
to bypass checkpoint responses and promote proliferation in
the presence of DNA damage.
RESULTS
A Unique Adaptation Defect in PBD-Defective Mutants
of CDC5 Exposed to DNA Damage
We have previously created a cdc5 mutant defective for the
phosphopeptide-binding activity of the PBD (i.e., cdc5-16) and
showed that it is unable to maintain its cellular ploidy but capable
of completing mitosis with relatively normal kinetics (Ratsima
et al., 2011). Given the mild mitotic phenotypes of this mutant,
we hypothesized that loss of phosphopeptide-binding activity
in Cdc5 might result in more severe effects on the adaptation
response to persistent DNA damage. To test this, we used a
temperature-sensitive (ts) allele of CDC13 to induce persistent
activation of the DNA damage checkpoint in Saccharomyces
cerevisiae (Weinert and Hartwell, 1988). Under non-permissive
conditions, cdc13-1 cells arrest in G2/M phase for several hours
before eventually adapting to the presence of DNA damage and
returning to a proliferative state (Toczyski et al., 1997). The ability
of wild-type CDC5 and cdc5-16 mutants to adapt to the check-
point-induced cell-cycle arrest was monitored using a microcol-
ony formation assay. Examination of cell morphology 4 hr after
inactivation of cdc13-1 indicated that both wild-type CDC5 and
cdc5-16 cells experience a tight checkpoint arrest inG2/Mphase
in the presence of DNA damage (Figure 1A). However, nearly
100% of wild-type cells adapted to the presence of persistent
DNA damage and formed microcolonies with three or more
cell bodies 24 hr after cdc13-1 inactivation, whereas %25% ofCell Rcdc5-16cellswereable todo the sameunder identical conditions
(Figure 1A). Remarkably, a large fraction ofcdc5-16cells arrested
with a unique terminal morphology characterized by a giant
mother cell body with a normal-sized bud (see 30-hr panel in Fig-
ure 1A). Although cdc mutants are known to be metabolically
active and continue cellular growth during cell-cycle arrest, the
size attained by cdc13-1 cdc5-16 mutants during their arrest
largely exceeds that seen in typical cdc mutants (e.g., 2.5-
fold volume increase for cdc13-1 mutants; Johnston et al.,
1977). Most cells in the cdc5-16 population showed this unique
asymmetry between mother and bud sizes, although equally
sized mother and bud cells could also be detected at a low fre-
quency. Collectively, these results indicate that the PBD-depen-
dent phosphopeptide-binding activity of Cdc5 is essential for
adaptation to checkpoint-mediated cell-cycle arrest.
To gain more insight into the cause of the adaptation defect in
cdc5-16 mutants, we monitored Rad53 protein hyperphosphor-
ylation as a biochemical marker for the activation of the Mec1/
Tel1-dependent DNA damage checkpoint (Sanchez et al.,
1996; Sun et al., 1996). Transfer of cdc13-1 CDC5 cells to non-
permissive temperature resulted in an initial hyperphosphoryla-
tion of Rad53 followed by a progressive downregulation of
Rad53 phosphorylation status as cells adapted to persistent
DNA damage (Figure 1B). Whereas inactivation of cdc13-1 in a
cdc5-16 background also resulted in effective Rad53 hyper-
phosphorylation early in the time course, analysis of later time
points revealed that Rad53 became largely unphosphorylated
12 hr (or less) after exposure to DNA damage (Figure 1B). These
observations indicate that cdc5-16 mutants are capable of acti-
vating a robust checkpoint signaling response immediately after
DNA damage but that the signaling cascade is silenced more
rapidly in those cells than in wild-type cells. As a corollary, the
inability of cdc5-16 mutants to proliferate in the presence of
persistent DNA damage (i.e., the defining feature of adapta-
tion-defective cells; Figure 1A) cannot be explained by impaired
recovery from the signaling events leading to Rad53 activation.
Cdc5 PBD Activity Is Required for Resistance to DNA
Damage
The requirement for the PBDactivity of Cdc5 in checkpoint adap-
tation suggests that loss of this activity may affect cellular resis-
tance to genotoxic stress (Galgoczy and Toczyski, 2001). To
test this prediction, we compared the ability of wild-type and
cdc5-16mutants to proliferate in the presence ofmethylmethane
sulfonate (MMS; a DNA alkylating agent) and 4-nitroquinoline
1-oxide (4-NQO; a UV mimetic agent). Although all yeast strains
grow equally well under non-damaging conditions (YPD), growth
in the presence of MMS and 4-NQO revealed that cdc5-16 cells
are specifically defective in their ability to proliferate in the pres-
ence of DNA damage (Figure 1C). This was true when the mutant
was compared to either haploid or diploid wild-type cells (Fig-
ure 1C), a relevant issue in the case of cdc5-16 mutants since
they are known to lose ploidy control and evolve to a stable
diploid state (i.e., from an initial haploid state; Ratsima et al.,
2011). As expected, the DNA damage sensitivity of cdc5-16
mutants is not as pronounced as that of a bona fide DNA repair
mutant, xrs2D. The kinase-specific mutant cdc5-77 also dis-
played sensitivity to DNA damage, which became increasinglyeports 14, 1422–1434, February 16, 2016 ª2016 The Authors 1423
Figure 1. Cdc5 PBD Activity Is Essential for Adaptation to DNA Damage and Resistance to Genotoxic Stress
(A) CDC5 cdc13-1 and cdc5-16 cdc13-1 double-mutants cells were incubated at 32C for 4 hr before being plated on solid YEPD. Microcolony formation was
monitored after 4, 10, 24, and 30 hr of incubation at restrictive temperature. The fraction of cells forming microcolonies at each time point is indicated in graphs
below the micrographs. Means ± SEM of three independent experiments are shown. The scale bar corresponds to 10 mm. The cell/microcolony outlines were
marked with a dotted line. Only genotype differences are described in panel notations.
(B) Phosphorylation status of Rad53 in cdc13-1 and cdc13-1 cdc5-16 cells experiencing persistent DNA damage. Samples of cells were collected and processed
for immunoblot analysis at the indicated time points. As previously observed, phosphorylation of Rad53 induced the appearance of a slower-migrating form of the
protein after electrophoresis (Sanchez et al., 1996; Sun et al., 1996).
(C) The DNA damage sensitivity of cdc5-16 mutants (two independent strains) was compared to wild-type controls and strains carrying cdc5-77 or xrs2D.
Sensitivity was evaluated on medium containing MMS or 4-NQO at various temperatures. Note that the effect of the DNA damaging agents was more severe at
higher temperatures. This explains why higher doses were used at 22C than at 30C and above.
(D) DNA damage sensitivity of cells carrying rad9D and cdc5-16 mutations.more severe at higher temperatures, consistent with the condi-
tional nature of this allele (Figure 1C). Together, these data indi-
cate that the PBD and kinase activities of Cdc5 are important
for cell viability and efficient proliferation under genotoxic stress.
We next performed a genetic analysis to determine the impact
of losing checkpoint activity in adaptation mutants. Specifically,
we constructed a rad9D cdc5-16 double-mutant strain and
compared its sensitivity to DNA-damaging agents with that of in-
dividual rad9D and cdc5-16mutants. As can be observed in Fig-
ure 1D, the proliferative capacity of rad9D cdc5-16 cells was
identical to that of rad9D cells in medium containing various con-
centrations of 4-NQO, thereby indicating that both mutations are
epistatic for their sensitivity to DNA damage.1424 Cell Reports 14, 1422–1434, February 16, 2016 ª2016 The AuthCDC5 Overexpression Bypasses the Need for PBD
Activity in Checkpoint Adaptation
Our previous results suggest that PBD-mediated phospho-tar-
geting of Cdc5 to specific substrates or cellular structures is
important to promote adaptation to DNA damage or, alterna-
tively, that Cdc5’s PBD confers a unique non-targeting function
that is essential to induce adaptation. To discriminate between
these two possibilities, we asked whether overexpression of
cdc5-16 would induce adaptation to DNA damage. If the PBD
acts by targeting Cdc5 to specific substrates, one would predict
that increasing Cdc5-16 levels in cells should functionally
compensate for an impaired targeting function (by increasing
the likelihood that Cdc5-16 meets its substrates), but not forors
Figure 2. Overexpression of the PBD-
Deficient Mutant of CDC5 Induces Adap-
tation to DNA Damage and Checkpoint
Inactivation
(A) cdc13-1 strains overexpressing either wild-
type Cdc5 (PGAL1-CDC5) or the PBD-deficient
mutant Cdc5-16 (PGAL1-cdc5-16) were assayed
for microcolony formation on YEPR medium sup-
plemented with 2% galactose. A cdc13-1 yeast
strain expressing Cdc5 at endogenous levels
(empty) was included as control. Scale bar, error
bars, and cell outlines are as defined in Figure 1.
(B) Rad53 phosphorylation status in cdc13-1
cells overproducing CDC5. Under our SDS-PAGE
conditions, overexpression of Cdc5 reduces the
levels of Rad53 phosphorylation, as evidenced
by the appearance of hypophosphorylated (i.e.,
partially retarded) and non-phosphorylated forms
of the protein. Cells in log phase were grown
at restrictive temperature for 2 hr before over-
expression was induced for three additional hours
by addition of 2%galactose to the growthmedium
(YEPR). Cellular extracts were probed with anti-
HA tag (top), anti-Cdc5 (middle), and anti-Nsp1
(bottom; loading control) antibodies.the complete loss of a unique (but currently unknown) biochem-
ical activity required for adaptation. Consistent with the former
hypothesis, Figure 2A shows that overexpression of cdc5-16 us-
ing the GAL1 promoter in cdc13-1mutants led to more effective
adaptation in these cells relative to a non-overexpressing control
strain (i.e., empty vector). Specifically, approximately half of the
cdc5-16-overexpressing cells formed microcolonies within 5 hr
of DNA damage exposure, while non-overexpressing cells
reached a similar level of adaptation with a 2 hr delay (cf., 7-hr
time point; Figure 2A). Likewise, monitoring Rad53 phosphoryla-
tion status revealed that this protein wasmore rapidly inactivated
by dephosphorylation in cdc13-1 cells overexpressing cdc5-16
than in control cells (Figure 2B). Interestingly, the rate of micro-
colony formation and kinetics of Rad53 dephosphorylation
were virtually identical in CDC5- and cdc5-16-overexpressing
cells (Figures 2A and 2B), thereby indicating that Cdc5 PBD
does not contribute a functionally unique biochemical activity
to the adaptation process. Consistent with this view, overex-
pression of a PBD-deleted version of Cdc5 resulted in a similar
increase in adaptation kinetics relative to control cells (Figures
S1A and S1B). From a mechanistic perspective, our results sug-
gest that the adaptation defect of cdc5-16mutants is the conse-
quence of ineffective targeting of the kinase to specific sub-
strate(s) or structure(s) in cells, and that increasing Cdc5-16Cell Reports 14, 1422–1434, Fconcentration in vivo can effectively
compensate for the absence of sub-
strate-targeting function in PBD mutants.
PBD-Mediated Localization of Cdc5
at the SPB Is a Prerequisite for the
Adaptation Response
How might the PBD promote Cdc5 func-
tion during adaptation to DNA damage?We have previously shown that the phosphopeptide-binding ac-
tivity of the PBD is responsible for the enrichment of Cdc5 at
SPBs (Ratsima et al., 2011). This observation suggests that the
adaptation defect of cdc5-16mutants may be due to a reduction
in Polo kinase activity at the SPBs, where Cdc5’s specific tar-
get(s) for adaptation may be located. To test this notion, we
asked if the adaptation defect of cdc5-16 cells could be rescued
by re-targeting Cdc5 constitutively to SPBs using a fusion be-
tween the SPB localization signal of Bbp1 and cdc5-16 (Park
et al., 2004; Ratsima et al., 2011). The cdc5-16-bbp1 mutant is
viable when expressed from the CDC5 promoter/locus, which
allowed us to conduct a standard microcolony formation assay
(Ratsima et al., 2011). Remarkably, enforcing SPB localization
of the Cdc5-16 protein allowed this mutant to induce efficient
adaptation to persistent DNA damage, whereas cells expressing
the unmodified version of cdc5-16 showed little adaptation
during the same time frame (Figure 3A). In fact, the kinetics of
microcolony formation after cdc13-1 inactivation were essen-
tially identical between wild-type and cdc5-16-bbp1 mutant
cells (Figure 3A; see graph), indicating a complete rescue of
the PBD defect in the SPB-targeted mutant. Likewise, kinetics
of Rad53 phosphorylation and dephosphorylation were recov-
ered to almost normal levels in cdc5-16-bbp1 cells relative to
cdc13-1 controls (Figure 3B; also compare with cdc5-16mutantebruary 16, 2016 ª2016 The Authors 1425
Figure 3. Localization of Cdc5-16 at the
SPB Is Sufficient to Promote Adaptation
and Resistance to DNA Damage
(A) Adaptation to DNA damage was determined
in cdc13-1 strains expressing wild-type CDC5,
cdc5-16, and the chimeric mutants cdc5-16-bbp1
or cdc5-DPBD-CNM67. The microcolony forma-
tion assay was performed as before. Scale bar,
error bars, and cell outlines are as defined in Fig-
ure 1. Only genotype differences are mentioned in
panel notations.
(B) Phosphorylation status of Rad53 protein in
cdc13-1 cells expressing Cdc5 chimeras.
(C) DNA damage sensitivity of cdc5-16-bbp1
mutants and control yeast strains growing on
medium containing various concentrations of
4-NQO at room temperature.in Figure 1B). Consistent with this, re-targeting of Cdc5-16-bbp1
to SPBs rescued the hypersensitivity of cdc5-16 cells to
DNA-damaging agents (Figure 3C). Taken together, these results
reveal that the function performed byCdc5 during the adaptation
response is dependent on its localization to the SPBs.
We next asked whether the phosphopeptide-binding activity
of the PBD or some other biochemical activity associated with
this domain is required for adaptation to DNA damage. Recent
studies point out to the fact that pre-phosphorylation of PLK sub-
strates is not always required for PBD binding and that mutations
that normally affect the phosphopeptide-binding activity of
PBDs do not prevent phospho-independent binding to PLK sub-
strates (Archambault et al., 2008; Chen and Weinreich, 2010;
Garcı´a-Alvarez et al., 2007; Rossio et al., 2010). To rule out the1426 Cell Reports 14, 1422–1434, February 16, 2016 ª2016 The Authorspossibility that a function other than the
phosphopeptide-binding activity of the
PBD is responsible for the phenotype
observed in cdc5-16 mutants, we moni-
tored the adaptation response in yeast
strains lacking the entire PBD of Cdc5.
Since deletion of Cdc5 PBD is lethal in
yeast (Park et al., 2004; Ratsima et al.,
2011), we replaced the sequence of this
domain by that of a SPB component,
Cnm67, to restore the localization of trun-
cated Cdc5 at the SPB (i.e., cdc5-DPBD-
CNM67; previous experiments revealed
that cdc5-DPBD-bbp1 is not functional;
Park et al., 2004). Remarkably, cells car-
rying the cdc5-DPBD-CNM67 chimera
at the CDC5 locus are viable and grow
well when the fusion allele is expressed
as the sole source ofCDC5 in cells. More-
over, cdc5-DPBD-CNM67 mutants were
able to adapt to the presence of persis-
tent DNA damage, although with a slight
delay or reduction in microcolony forma-
tion 24 hr post-damage (Figure 3A). The
delay in adaptation kinetics of cdc5-
DPBD-CNM67 mutants relative to cdc5-16-bbp1 cells might reflect additional functions associated
with the cdc5-16-bbp1 chimera or incomplete folding/activity
of the Cnm67-fusion protein. Nevertheless, the similarity in the
phenotypes of the PBD-deleted and phosphopeptide-binding-
defective mutants of CDC5 indicate that a key function of the
PBD is to anchor Cdc5 to SPBs in a phospho-dependent
manner, where it can promote an effective adaptation response
to persistent DNA damage.
Bfa1-Dependent and -Independent Roles for Cdc5 in
Adaptation to DNA Damage
Wenext sought to identify the SPB substrate that Cdc5 regulates
during the adaptation response. A prime candidate for this would
be Bfa1, since it has previously been suggested that inhibition of
(legend on next page)
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this SPB component is important for Cdc5-induced adaptation
to DNA damage (Hu et al., 2001; Liang and Wang, 2007; Va-
lerio-Santiago et al., 2013). Importantly, the mechanistic basis
for the regulation of Bfa1 during the DNA damage response is
still unclear, as one study proposes a direct phosphorylation
of Bfa1 by Cdc5 (Valerio-Santiago et al., 2013), while others
suggest an indirect involvement of Cdc5 via phosphorylation
of an unidentified effector of Bfa1 (Hu et al., 2001; Liang and
Wang, 2007). To assess the potential requirement for Cdc5
PBD activity in the inhibition of Bfa1 during adaptation, we
conducted a cdc13-1 microcolony assay in cdc5-16 cells
in the presence or absence of BFA1 function. Whereas
cdc13-1 cdc5-16 cells were incapable of forming microcolonies
in the adaptation assay, inactivation of Bfa1 allowed the
cdc13-1 cdc5-16 bfa1D triple-mutant cells to adapt to the pres-
ence of DNA damage with normal kinetics relative to cdc13-1
controls (Figure 4A). This complete bypass of the adaptation
defect of cdc5-16 cells indicates that Bfa1 acts negatively on
the adaptation response (as previously observed; Valerio-San-
tiago et al., 2013) and that removal of this negative regulation al-
lows PBD-defective mutants of CDC5 to adapt more readily to
the presence of DNA damage. Consistent with this observation,
we confirmed that cells defective in Bub2, the binding partner of
Bfa1, also suppress the adaptation phenotype of cdc5-16 cells
(Figure S2).
Next, we asked whether Bfa1 operates downstream or in par-
allel with Cdc5 in the adaptation process. To answer this ques-
tion, we constructed cdc13-1 cells carrying alleles of BFA1 that
are resistant to Cdc5 inhibitory phosphorylation, bfa1-4a and
bfa1-11a (Hu et al., 2001; Kim et al., 2012). In the absence of
CDC5 overexpression, these cells adapt to DNA damage with
slightly slower kinetics than cells carrying wild-type BFA1,
consistent with a housekeeping role of Cdc5 in relieving the
Bfa1 inhibition of the mitotic exit network (cf. 7-hr time point
in Figure 4B) (Hu et al., 2001). In striking contrast, overexpres-
sion of CDC5 in cdc13-1 bfa1-4a or cdc13-1 bfa1-11a dou-
ble-mutant cells advanced the kinetics of adaptation to the
same extent as observed when overexpression was performed
in a BFA1 genetic background (Figure 4C). Specifically, under all
conditions, the rate of microcolony formation was comparable
in cells overexpressing CDC5 and showed advanced kinetics
of adaptation relative to non-overexpressing cdc13-1 control
cells (cf. 7-hr time points in Figures 4B–4C). Interestingly, eval-
uation of Bfa1 phosphorylation status revealed no difference in
the kinetics and extent of modification of this protein in the
presence of DNA damage in cdc5-16 mutants and control cells
(Figure 4D). These results indicate that CDC5 can promoteFigure 4. Cdc5 Can Promote Adaptation Independently of Bfa1
(A) Loss of Bfa1 activity suppresses the adaptation defect of cdc5-16mutants. W
processed for microcolony formation assay at non-permissive temperature.
(B) Microcolony formation in bfa1mutants resistant to Cdc5 phosphorylation. cdc1
mutants were assayed for microcolony formation at 32C.
(C) Cells expressing the phospho-resistant alleles of BFA1 were monitored for ad
error bars, and cell outlines are as defined in Figure 1.
(D) Phosphorylation status of Bfa1 in CDC5 and cdc5-16 cells experiencing cdc13
immunoblot analysis at the indicated time points. Phosphorylation of Bfa1 resulte
Only genotype differences are mentioned in panel notations.
1428 Cell Reports 14, 1422–1434, February 16, 2016 ª2016 The Authadaptation independently of its ability to inhibit Bfa1 by phos-
phorylation in bfa1-4a and bfa1-11a mutant cells. Taken
together with other studies in the literature (Hu et al., 2001;
Valerio-Santiago et al., 2013), our results suggest that Cdc5
acts on Bfa1 and a yet to be defined effector substrate to regu-
late adaptation to DNA damage.
Regulation of Cdc5 Kinase Activity in Cells Experiencing
DNA Damage
Our previous results suggest that Cdc5 regulates its effectors of
the adaptation response by PBD-mediated targeting and phos-
phorylation. However, the status of Cdc5 kinase activity during
the DNA damage response is currently unclear. Previous studies
have indicated that Cdc5 kinase activity is high in cells experi-
encing DNA damage (Hu et al., 2001), whereas others have pro-
posed a partial downregulation during the early stages of the
DNA damage response (Valerio-Santiago et al., 2013; Zhang
et al., 2009). Although Cdc5 downregulation would nicely explain
how a tight checkpoint arrest might be enforced, it is still not
clear how Cdc5 would be reactivated to promote adaptation in
the late response to DNA damage. To address this issue, we re-
visited the notion that phosphorylation of canonical Cdc5 sub-
strates is affected by the presence of DNA damage. We focused
on two early mitotic targets of Cdc5, Swe1 and Scc1/Mcd1,
since these proteins are normally phosphorylated in pre-meta-
phase cells, consistent with the point of arrest of cdc13-1 mu-
tants (Alexandru et al., 2001; Sakchaisri et al., 2004; Weinert
and Hartwell, 1988). As can be seen in Figure 5A, Scc1-Myc
migrated in SDS-PAGE as a single band in wild-type unsynchro-
nized cells at 23C, whereas Cdc5-dependent phosphorylation
shifted the protein to a higher molecular mass in nocodazole-ar-
rested cells (Alexandru et al., 2001). Importantly, under identical
(i.e., non-permissive) conditions, Scc1-Mycwas efficiently phos-
phorylated in cdc13-1 mutant cells (Figure 5A). The hyperphos-
phorylation of Scc1-Myc seen in cdc13-1 cells was caused by
the presence of DNA damage during cell-cycle arrest because
addition of MMS to nocodazole-arrested wild-type cells also re-
sulted in hyperphosphorylation of this substrate. Similar experi-
ments with Swe1 also confirmed normal Cdc5-mediated phos-
phorylation of this substrate after DNA damage. Specifically,
we monitored the degradation of Swe1 that occurs upon Cdc5
phosphorylation in early mitosis (Sakchaisri et al., 2004). Fig-
ure 5B shows that Swe1 is degraded with similar kinetics in
undamaged CDC13 cells and in cdc13-1 mutants experiencing
DNA damage. Taken together, these results indicate that phos-
phorylation of early mitotic substrates by Cdc5 is not downregu-
lated during the DNA damage response.ild-type or cdc5-16mutant cells carrying cdc13-1 with and without bfa1Dwere
3-1 cells expressing wild-typeBFA1, bfa1-4a, or bfa1-11a phosphorylation site
aptation to DNA damage in the presence of Cdc5 overexpression. Scale bar,
-dependent DNA damage. Samples of cells were collected and processed for
d in the formation of a retarded band following electrophoresis (Hu et al., 2001).
ors
Figure 5. Cdc5 Kinase Activity during the
DNA Damage Response
(A) Cdc5-mediated phosphorylation of Scc1/
Mcd1 was monitored by gel retardation assay.
Samples of cells from log phase or nocodazole-
arrested cultures were processed for extract
preparation, SDS-PAGE and immunoblotting.
MMS was added at a concentration of 0.1% for
45 min in part of the culture of wild-type cells
arrested in nocodazole. Cellular extracts were
probed with anti-Myc to detect Scc1-Myc phos-
phorylation-induced gel shift.
(B) Cultures of wild-type and cdc13-1mutant cells
were arrested in G1 and released into a synchro-
nous cell cycle at non-permissive temperature.
Samples were taken at intervals and processed for
immunoblotting as described in (A). Cellular ex-
tracts were probed with anti-Swe1 monoclonal
antibodies to detect the Cdc5-induced disap-
pearance of this protein in early mitosis. Pgk1 was
used as loading control. The budding index of the
culture is shown below the gels.Role of the DNA Damage Signaling Machinery in
Cdc5-Dependent Adaptation
Which substrate is the critical target of Cdc5 during adaptation to
DNA damage? A number of candidate effectors have been pro-
posed, including several involved in DNA damage signaling and
repair (Hu et al., 2001; Liang and Wang, 2007; Schleker et al.,
2010; Valerio-Santiago et al., 2013; Vidanes et al., 2010; Zhang
et al., 2009). Among those, the Sae2 endonuclease stands out
because of its importance in DNA damage signaling (Clerici
et al., 2006; Donnianni et al., 2010). To determine whether
Sae2 is the downstream effector of Cdc5 during adaptation,
we took advantage of the fact that Cdc5 overexpression pro-
motes adaptation in cdc13-1 cells, and removal of Cdc5’s down-
stream effector in this context should prevent adaptation (Don-
nianni et al., 2010; Vidanes et al., 2010). We performed
microcolony formation and Rad53 dephosphorylation assays
comparing cdc13-1 SAE2 and cdc13-1 sae2D strains overex-
pressing CDC5 under the GAL1 promoter. Figures 6A and 6B
show that loss of SAE2 does not detectably impact the rate of
microcolony formation and kinetics of Rad53 dephosphorylation
in the absence of Cdc5 overexpression. Moreover, it was
possible to increase the rate at which cells adapt to the cdc13-
1-dependent DNA damage when overproducingCDC5 irrespec-
tive of the SAE2 status of cells. Taken together, these results
demonstrate that Cdc5 can promote adaptation to cdc13-1-
induced damage independently of SAE2 activity. This SAE2-
independent response may reflect a degree of specificity in
Cdc5’s contribution to adaptation, since Sae2 plays a significant
role in checkpoint adaptation in cells exposed to other types
of DNA damage (i.e., non cdc13-induced; Clerici et al., 2006;
Donnianni et al., 2010).
We next considered other regulators of the DNA damage
response as potential effectors of Cdc5 in the adaptation
response. In particular, we focused on DNA repair proteins that
are known targets of Cdc5 as well as proteins that have been
previously connected to checkpoint recovery/inactivation after
completion of DNA repair. These candidates include the HollidayCell Rjunction resolvases Yen1 and Mus81 (Matos et al., 2011), the
scaffold protein Slx4 (Ohouo et al., 2013), and the phosphatases
PP1, PP2B, and PP4 (Bazzi et al., 2010; Hanway et al., 2002;
Keogh et al., 2006). Figure S3 shows that inactivation of these
proteins did not interfere with the initial phosphorylation of
Rad53 in response to cdc13-1 inactivation. Moreover, loss of
these proteins did not detectably affect the ability of Cdc5 to
downregulate checkpoint signaling. Specifically, upon CDC5
overexpression, loss of Rad53 hyperphosphorylation occurred
with similar kinetics in all mutant strains compared to control
cells (Figure S3). Taken together with previous observations
(Vidanes et al., 2010), our genetic dependency experiments sug-
gest that Cdc5 acts in parallel or downstream of the checkpoint-
signaling cascade to promote adaptation to persistent DNA
damage. In light of this, the direct target of Cdc5 in adaptation
may not be the DNA damage machinery.
The RSC Chromatin-Remodeling Complex Promotes
Cdc5-Dependent Adaptation
The RSC complex is an evolutionarily conserved 17-component
chromatin-remodeling enzyme that plays essential roles in
genome expression and stability. Two subunits of this complex,
Rsc1 and Rsc2, were identified as high probability substrates for
Cdc5 in recent bioinformatics analyses (Snead et al., 2007).
Moreover, it is known that RSC components are required to pro-
mote adaptation to cell-cycle arrest induced by the spindle as-
sembly checkpoint (SAC), a process analogous to DNA damage
adaptation in budding yeast (Rossio et al., 2010). These observa-
tions prompted us to ask if RSC components are required for
adaptation to DNA damage, and if so, whether they act down-
stream of Cdc5 in this process. To answer these questions, we
deleted two genes encoding non-essential subunits of the RSC
complex (RSC1 and RSC2) in a cdc13-1 mutant background
and monitored checkpoint activation in these cells. We conduct-
ed these experiments on a shorter timescale (7 hr) to avoid con-
founding effects associated with long-term transcriptional
changes in rsc mutants (Angus-Hill et al., 2001). Upon inductioneports 14, 1422–1434, February 16, 2016 ª2016 The Authors 1429
Figure 6. Cdc5 Acts Downstream or in
Parallel to Sae2 during the Adaptation
Response
(A) The role of SAE2 in microcolony formation in
populations of cdc13-1 cells overexpressing Cdc5
was monitored at restrictive temperature. Non-
overexpressing cells were included as controls.
Scale bar, error bars, and cell outlines are as
defined in Figure 1. cdc13-1 was omitted from
genotype notation as before.
(B) The strains described above were also used
to monitor Rad53 phosphorylation status during
adaptation (as described in Figure 2B).of cdc13-1 damage, rsc1D and rsc2D mutants established a
strong cell-cycle arrest, as evidenced by the formation of large
budded cells in >90% of the population and hyperphosphoryla-
tion of Rad53 2 hr after cdc13-1 inactivation (Figures 7A–7C),
thereby indicating robust checkpoint activation in these cells.
However, loss of the RSC subunit significantly impaired the abil-
ity of cdc13-1mutants to adapt to DNA damage (Figure 7A). The
more profound impact of rsc2Dmutants relative to rsc1D on the
adaptation process is consistent with those subunits being part
of distinct forms of the RSC complex, each acting in semi-over-
lapping functions in vivo (Cairns et al., 1999). Since RSC compo-
nents are involved in adaptation, we took advantage of theCDC5
overexpression system to ask if RSC activity acts downstream or
upstream of Cdc5 to bypass the DNA damage checkpoint.
Remarkably, inactivation of the RSC complex prevented full
adaptation of cdc13-1 cells overexpressing CDC5 (Figure 7B).
Once again, rsc2D mutants had a stronger effect than rsc1D
on CDC5-induced adaptation, but both had significantly
impaired levels of adaptation by the end of the experiment (Fig-
ure 7B). Rad53 was dephosphorylated with similar kinetics in
RSC2 and rsc2D cells after overexpression of CDC5 (Figure 7D;
compare 7-hr time points), thereby indicating that the adaptation
defect of RSC complex mutants does not correlate with Rad53
phosphorylation status.
To gain further mechanistic insights into the Cdc5-RSC rela-
tionship, we performed co-immunoprecipitation experiments to
determine if Cdc5 interacts physically with the RSC complex
during the DNA damage response. As previously observed (Ros-
sio et al., 2010), we detected a phosphorylation-independent1430 Cell Reports 14, 1422–1434, February 16, 2016 ª2016 The Authorsbasal interaction between myc-tagged
Rsc2 and endogenous Cdc5 in the
absence of DNA damage (i.e., 23C;
compare lanes 4 and 5 in Figure 7E). In
contrast, analysis of cdc13-1 cells
growing at 32C revealed that Cdc5 inter-
acts strongly with the RSC complex in the
presence of DNA damage and that this
interaction is significantly reduced in cells
lacking Cdc5 phosphopeptide-binding
activity (cdc5-16; compare lanes 6 and
7 in Figure 7E). Cdc5 was not immuno-
precipitated from cells expressing un-
tagged Rsc2, thereby indicating that theinteraction is specific. Taken together, these results indicate
that the RSC complex is a regulator of the adaptation response
to DNA damage in budding yeast and that it acts together with
Cdc5 to promote this process.
DISCUSSION
The contribution of PLKs to cell-cycle progression has been
extensively studied in the past, but the mechanisms underlying
their specific contribution to the DNA damage response—partic-
ularly to the adaptation to persistent DNA damage—still remain
elusive (Archambault et al., 2015; Serrano and D’Amours,
2014). We have previously shown that the PBD and kinase activ-
ities of Cdc5 do not contribute equally to all PLK functions during
cell division and that some mitotic processes requiring Cdc5 ac-
tivity are not detectably affected by the loss of PBD-mediated
phosphopeptide-binding activity (Ratsima et al., 2011). In
contrast, we show here that the PBD activity of Cdc5 is abso-
lutely crucial for the adaptation response to DNA damage.
Together with the loss of ploidy control, the adaptation defect
of cdc5-16 mutants is one of the most dramatic consequences
that is associated with loss of PBD activity in yeast.
Our study reveals that the PBD likely promotes adaptation by
enabling phosphorylation-dependent binding of Cdc5 to a key
effector protein that is located in the vicinity of SPBs. Consistent
with this, our genetic analyses excluded predominantly nuclear
DNA repair/checkpoint effectors as downstream targets of
Cdc5 in the adaptation response. Experiments using Cdc5 phos-
phosite mutants of Bfa1 also suggest that Bfa1 is not the sole
Figure 7. The RSC Chromatin-Remodeling
Complex Promotes CDC5-Dependent
Adaptation to DNA Damage
(A and B) cdc13-1mutants carrying either rsc1D or
rsc2D deletions were processed to determine their
adaptation capacity at non-permissive tempera-
ture with (B) andwithout (A)CDC5 overexpression.
Scale bar, error bars, and cell outlines are as
defined in Figure 1.
(C and D) Phosphorylation status of Rad53 in
RSC2-defective cells experiencing DNA damage
with (D) and without (C) CDC5 overproduction.
(E) Cdc5 and RSC interact in a PBD-dependent
manner in cdc13-1 cells. Myc-tagged Rsc2
was immunoprecipitated from extracts prepared
of cells incubated at permissive (23C) or non-
permissive (32C) temperature for cdc13-1. The
immunoprecipitates were processed for immu-
noblot analysis using anti-Myc and anti-Cdc5
antibodies. An untagged strain was used as
negative control.target of Cdc5 in this process. This interpretation is consistent
with the fact that (1) the adaptation process depends on the
PBD phosphopeptide-binding activity of Cdc5, (2) the PBD is
highly-specific for binding to Cdk1-phosphorylated substrates
(Elia et al., 2003), (3) loss of Cdk1 activity does not prevent
Cdc5-dependent phosphorylation of Bfa1 (Valerio-Santiago
et al., 2013), and (4) overactivation of Cdk1 does not bypass
checkpoint responses (Stueland et al., 1993). Our data do not
exclude an important role of Bfa1 as a target for Cdc5 in the adap-
tation response, but rather indicate thatCdc5acts in anadditional
biochemical pathway that has a considerable impact on the pro-
cess of adaptation. In fact, we envision that Cdc5 could have a
dual contribution to the adaptation process: the first one via its
housekeeping function in activating mitotic exit (i.e., Bfa1 inhibi-
tionandCdc15activation;RockandAmon,2011), and thesecond
one via its DNA damage-specific function mediated by the RSC
pathway identified in this study. It is a formal possibility that the
Bfa1-independent contribution of Cdc5 to checkpoint adaptation
is mediated through a currently unknown regulatory input on the
mitotic exit network, since overexpression ofCDC5 can suppress
theCdc14activationdefects of someMENmutants (Visintin et al.,
2003). However, the fact thatCDC5 overexpression does not effi-Cell Reports 14, 1422–1434, Fciently suppress theconditional lethalityof
several mitotic exit mutants (i.e., cdc15-2,
dbf2-2, and cdc14-1; Jaspersen et al.,
1998) but is capable of inducing full adap-
tation (Vidanes et al., 2010) suggests that
some of Cdc5 functions in adaptation are
exerted independently of the mitotic exit
pathway. Consistent with this interpreta-
tion, PBD-defective cdc5 mutants show
very little, if any, mitotic exit defect (Rat-
sima et al., 2011). Moreover, the fact that
mitotic exit mutants are proficient at cell-
cycle re-entry when released from a pro-
longed mitotic arrest (Manukyan et al.,2011) indicates that failure to adapt in cdc5-16 mutants is not a
reflection of a mitotic-exit-related aftereffect on subsequent
budding and proliferation. While we recognize the possibility
that the role of CDC5 in adaptation and cell-cycle progression
could be overlapping, the fact that cdc5-16mutants show strong
adaptation defects without overt proliferation phenotypes (typical
of other alleles of CDC5; Ratsima et al., 2011) argues that the
mechanistic basis underpinning the adaptation and cell-cycle
functions of CDC5 can be separated functionally.
Importantly, we identified the RSC chromatin-remodeling
complex as a key component that promotes Cdc5-dependent
adaptation. Consistent with this, it has previously been shown
that RSC components bind directly to Cdc5 during mitosis (Ros-
sio et al., 2010). Whether RSC components are also phosphory-
lated by Cdc5 remains an open question. However, we note that
several subunits of the RSC complex were recently identified as
high-probability substrates for Cdc5 and also contain a large
number of PBD consensus binding sites (at least 28; Snead
et al., 2007). This, together with the fact that the RSC complex
contains 17 subunits (Cairns et al., 1999), makes the identifica-
tion of the actual Cdc5 phosphorylation/PBD-binding sites in
RSC subunits a daunting task that will be the subject of a futureebruary 16, 2016 ª2016 The Authors 1431
study. Beyond the kinase-substrate issue, our data clearly
establish the RSC complex as a key contributor to the Cdc5-
dependent pathway for adaptation to DNA damage. It is inter-
esting to note that in addition to their adaptation defect, cdc5-
16 and 3 different mutants of the RSC complex (sfh1, rsc3, and
htl1) share a similar defect in the maintenance of genome ploidy
(Campsteijn et al., 2007; Lanzuolo et al., 2001). The fact that
adaptation and ploidy defects are relatively uncommon pheno-
types that are both observed in RSC and cdc5mutants reinforce
our conclusion that these proteins work together to promote
genome stability. Finally, we note that Cdc5 and the RSC com-
plex have also been linked to the adaptation response to persis-
tent SAC activation (Rossio et al., 2010). This raises the intriguing
possibility that adaptation to various types of cell-cycle inhibitory
signals is mediated through a single universal mechanism.
Centrosomes/SPBs have a well-established function as
microtubule organizing centers in cells. Interestingly, the notion
that the centrosome can also act as a key signaling platform
for cellular processes unrelated to microtubule organization
has gainedmuchmomentum in recent years (reviewed in Arquint
et al., 2014). Our data indicate that the yeast centrosome plays a
key organizing function in the promotion of effective adaptation
to DNA damage via PBD-mediated enrichment of Cdc5. We
envision that the specific localization of Cdc5 to this organelle
enables phosphorylation of an essential effector of adaptation
that is unlikely to be constitutively associated with centrosomes.
The phosphorylation of Cep55 by centrosome-localized Plk1,
and its subsequent relocation to the spindle midzone inmamma-
lian cells (Fabbro et al., 2005) provides a compelling paradigm
for how Cdc5 might activate and/or promote the relocation of
its immediate effector during the adaptation response. This
downstream effector could be the RSC complex itself, since
chromatin-remodeling complexes related to RSC are known to
associate with centrosomes and/or its components in mamma-
lian cells (Euskirchen et al., 2011; Sillibourne et al., 2007). The
downstream effector could also be a currently unknown regu-
lator of RSC. Nevertheless, our data now provide a clear demon-
stration of the functional importance of localizing effectors of the
DNA damage response to SPBs/centrosomes to ensure cellular
resistance to DNA damage. In this context, the importance
of Cdc5’s PBD activity cannot be overstated, since loss of this
activity impairs SPB localization (Ratsima et al., 2011; Song
et al., 2000), reduces cellular resistance to DNA damage, and
is associated with wide-scale genome instability.
Finally, our study also unravels an unexpected benefit of
localizing Polo kinase activity to SPBs in cdc5-DPBD-CNM67
mutants. Indeed, this allowed cells to not only mount an effec-
tive adaptation response to DNA damage but also survive and
grow normally in the complete absence of PBD activity. Previ-
ous genetic analyses have indicated that the phosphopeptide-
binding activity of Cdc5 PBD is dispensable for viability in
yeast but that full deletion of the PBD results in lethality
(Park et al., 2004; Ratsima et al., 2011). Our study now reveals
that the essential function of the PBD for cellular viability can
be effectively restored in cdc5-DPBD cells by directing Polo ki-
nase activity to SPBs. Hence, our work unraveled key insights
into the mechanisms used by Cdc5 to promote the mainte-
nance of genome integrity and ensure cell survival not only1432 Cell Reports 14, 1422–1434, February 16, 2016 ª2016 The Authunder DNA damage conditions but also during normal cell
proliferation.
EXPERIMENTAL PROCEDURES
Yeast strains used in this study are described in Table S1. Standard conditions
were used for yeast culture and genetic manipulations (Guthrie and Fink,
1991), as well as for microcolony formation assays (Toczyski et al., 1997; Vi-
danes et al., 2010), immunoblotting (Ratsima et al., 2011), and immunoprecip-
itation experiments (Rossio et al., 2010). Rat monoclonal antibodies 18D9-
G8A1 and 15F2 were generated against full-length recombinant Swe1 by
Me´diMabs and used in combination at a dilution of 1/250 each for the detec-
tion of endogenous Swe1 by immunoblot. All quantifications presented in this
study represent the means ± SEM for three or more independent experiments.
An extensive description of all materials and methods is provided in Supple-
mental Experimental Procedures.
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